SpiralUp TCL Allograft
The SpiralUp® TCL Allograft System is an acellular dermal allograft intended to supplement the talocalcaneal ligament and as such, function as a dense, stable and spongey connective tissue layer. It is intended to improve the function of the foot, as well as conditions along the musculoskeletal (MSK) chain.
Talocalcaneal instability and peritalar subluxation are progressive conditions with far-reaching symptoms in a vast patient population. The SpiralUp TCL Allograft System is a unique approach to treating talocalcaneal instability and peritalar subluxation. The allograft is bullet shaped to support the anatomy of the canal and is engineered from acellular dermal tissue. It provides the necessary space in the sinus canal and also addresses ligamentous instability and peritalar subluxation. The SpiralUp implant is inserted across 80-90% of the sinus tarsi, it is able to stabilize the 3 facets (anterior, middle and posterior) of the subtalar joint more effectively than existing metal implants.
Key Features & Benefits:
- Pre-rolled, decellularized, freeze-dried, gamma sterilized human dermal allograft tissue
- Cannulated system
- Bullet shaped to support the anatomy of the tarsal canal
- Ease of implantation and removal
- No MRI restrictions
- Scaffold for tightening and integration of talocalcaneal ligaments
Anika’s Talus HemiCAP® is a joint restoration system designed to match the shape and contour of the individual patient’s cartilage surface and protect the remaining (healthy) cartilage of the talar dome. Indicated for hemiarthroplasty of the talar dome to treat patients with localized post-traumatic degenerative disease, necrosis associated with large unstable osteochondral fractures, or osteochondritis dissecans.
The system prevents further damage to the joint while maintaining the patient’s native anatomy and motion.
Key Features & Benefits:
- One implant for 3 surfaces: dome, ridge and medial wall
- Screw based fixation provides a stable implant
- Inlay components restore congruency & maintain existing biomechanics
- Implant protects subchondral bone and shares load with surrounding tissue
- Minimal bone and tissue removal maintains future options; “No Bridges Burned”
The SpiralUp TCL Allograft System is available in the US only.
The Talus HemiCAP is not available in the United States.
The SpiralUp TCL Allograft System is not available outside of the United States.
The Talus HemiCAP is approved for patients via CE Mark and other countries outside of the US. If you would like to learn more about the procedure performed in Europe, please contact:
Anika products may not be available in all geographies. Product availability is subject to the regulatory clearances in individual markets. Please reach out to your local representative or Contact Us if you have questions about specific market approvals.
For complete product information, including indications, contraindications, warnings, and precautions, please refer to the Instructions for Use found here.